Scandinavian ChemoTech AB (publ) (“ChemoTech”) meddelar idag att Robin Sukhia, styrelseledamot, har köpt ytterligare 3 000 aktier för cirka 75 500 SEK över börsen. Hans totala innehav uppgår nu till 13 000 aktier i ChemoTech.
Read moreIdag har ChemoTech tecknat ett avtal med det amerikanska företaget Diversified Consultant Group LLC som kommer att ansvara för att genomföra en förstudie. Denna studie är utformad för att identifiera hur ChemoTech ska agera i sin "Go-to-Market" -strategi när Bolaget lanserar sin produkt vetIQure i USA.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) meddelar idag att Martin Jerndal, styrelseledamot och större aktieägare, har köpt ytterligare 6 000 aktier för cirka 154 500 SEK över börsen. Hans totala innehav uppgår nu till 588 695 aktier i ChemoTech.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Robin Sukhia, board member, has bought further 3,000 shares for approximately SEK 75,500 over the stock exchange. His total holding now amounts to 13,000 shares in ChemoTech.
Read moreToday Scandinavian ChemoTech has signed an agreement with the US based company Diversified Consultant Group LLC that will be responsible for performing a feasibility study. This study is aiming to identify how Scandinavian ChemoTech should design a “Go-to-Market” strategy when launching its animal care product vetIQure in the USA.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Martin Jerndal, board member and major shareholder, has bought further 6,000 shares for approximately SEK 154,500 over the stock exchange. His total holding now amounts to 588,695 shares in ChemoTech.
Read more
